Citation
Wang, Huihui, et al. "The Genetic Sequence, Origin, and Diagnosis of SARS-CoV-2." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 39, no. 9, 2020, pp. 1629-1635.
Wang H, Li X, Li T, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629-1635.
Wang, H., Li, X., Li, T., Zhang, S., Wang, L., Wu, X., & Liu, J. (2020). The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 39(9), 1629-1635. https://doi.org/10.1007/s10096-020-03899-4
Wang H, et al. The Genetic Sequence, Origin, and Diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629-1635. PubMed PMID: 32333222.
TY - JOUR
T1 - The genetic sequence, origin, and diagnosis of SARS-CoV-2.
AU - Wang,Huihui,
AU - Li,Xuemei,
AU - Li,Tao,
AU - Zhang,Shubing,
AU - Wang,Lianzi,
AU - Wu,Xian,
AU - Liu,Jiaqing,
Y1 - 2020/04/24/
PY - 2020/03/12/received
PY - 2020/04/07/accepted
PY - 2020/4/26/pubmed
PY - 2020/8/22/medline
PY - 2020/4/26/entrez
KW - COVID-19
KW - Diagnosis
KW - Origin
KW - SARS-CoV-2
SP - 1629
EP - 1635
JF - European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
JO - Eur J Clin Microbiol Infect Dis
VL - 39
IS - 9
N2 - Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new infectious disease that first emerged in Hubei province, China, in December 2019, which was found to be associated with a large seafood and animal market in Wuhan. Airway epithelial cells from infected patients were used to isolate a novel coronavirus, named the SARS-CoV-2, on January 12, 2020, which is the seventh member of the coronavirus family to infect humans. Phylogenetic analysis of full-length genome sequences obtained from infected patients showed that SARS-CoV-2 is similar to severe acute respiratory syndrome coronavirus (SARS-CoV) and uses the same cell entry receptor, angiotensin-converting enzyme 2 (ACE2), as SARS-CoV. The possible person-to-person disease rapidly spread to many provinces in China as well as other countries. Without a therapeutic vaccine or specific antiviral drugs, early detection and isolation become essential against novel Coronavirus. In this review, we introduced current diagnostic methods and criteria for the SARS-CoV-2 in China and discuss the advantages and limitations of the current diagnostic methods, including chest imaging and laboratory detection.
SN - 1435-4373
UR - https://www.unboundmedicine.com/medline/citation/32333222/The_genetic_sequence_origin_and_diagnosis_of_SARS_CoV_2_
L2 - https://dx.doi.org/10.1007/s10096-020-03899-4
DB - PRIME
DP - Unbound Medicine
ER -